Sino Biopharmaceutical Overview

Sino Biopharmaceutical EBIT

EBIT (Earnings Before Interest and Taxes) analysis for SBHMY.

Quarterly EBIT

$1.70B

↑ 240.14% YoY

As of Jun 30, 2025

Annual EBIT (TTM)

$5.11B

↑ 287.62% YoY

Trailing 12 months ending Jun 30, 2025

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin